# Effect of Intravenous Hyoscine Butylbromide Injection on Labour in High Risk Women

> **NCT03055390** · PHASE4 · COMPLETED · sponsor: **Cairo University** · enrollment: 300 (actual)

## Conditions studied

- Vaginal Delivery

## Interventions

- **DRUG:** hyoscine butylbromide
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT03055390
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-11
- **Primary completion:** 2022-01-10
- **Final completion:** 2022-02-03
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2022-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03055390

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03055390, "Effect of Intravenous Hyoscine Butylbromide Injection on Labour in High Risk Women". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03055390. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*